Diagnostic radiation procedures and risk of prostate cancer

British Journal of Cancer

Volumn 98, Issue 11, 2008, Pages 1852-1856

  Myles, P ^a   Evans, S ^b   Lophatananon, A ^a,g   Dimitropoulou, P ^a,h   Easton, D ^c   Key, T ^d   Pocock, R ^e   Dearnaley, D ^f   Guy, M ^f   Edwards, S ^f   O'Brien, L ^f   Gehr Swain, B ^f   Hall, A ^b   Wilkinson, R ^f   Eeles, R ^b,f   Muir, K ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e BAUS Section of Oncology   (United Kingdom)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^g Chulabhorn Hospital Lak Si   (Thailand)

^h ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Case control; Epidemiology; Prostate; Radiation

Indexed keywords

ANAMNESIS; ARTICLE; BARIUM ENEMA; BARIUM MEAL; CANCER RISK; CONTROLLED STUDY; HIP RADIOGRAPHY; HUMAN; IONIZING RADIATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIODIAGNOSIS;

CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; PROSTATIC NEOPLASMS; RADIOGRAPHY; RISK FACTORS; UROGRAPHY;

EID: 44349085951     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604370     Document Type: Article

References (25)

1. Andrieu N, Easton D, Chang-Claude J, Rookus M, Brohet R, Cardis E (2006) Effect of Chest X-Rays on the risk of breast cancer among BRCA1/2 mutation carriers in the International BRCA1/2 Carrier Cohort Study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. J Clin Oncol 24: 3361-3366
2. Atkinson WD, Law DV, Bromley KJ, Inskip H (2004) Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-97. Occup Environ Med 61: 577-585
3. Baria K, Warren C, Roberts SA, West CM, Scott D (2001) Chromosomal radiosensitivity as a marker of predisposition to common cancers. Br J Cancer 84: 892-896
4. Beral V, Inskip H, Fraser P (1985) Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-1979. Br Med J 291: 440-447
5. Berrington de Gonzalez A, Darby S (2004) Risk of cancer from diagnostic x-rays: estimates for the UK and 14 other countries. Lancet 363: 345-351
6. Brenner DJ, Doll R, Goodhead DT, Hall EJ, Land CE, Little JB, Lubin JH, Preston DL, Preston RJ, Puskin JS, Ron E, Sachs RK, Samet JM, Setlow RB, Zaider M (2003) Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci USA 100: 13761-13766
7. Cormack J, Towson J, Flower M (2004) Radiation protection and dosimetry in clinical practice. In Ell P, Gambhir S (eds). In Nuclear Medicine in Clinical Diagnosis and Treatment. Churchill Livingstone: Edinburgh
8. CRUK (2007) Prostate Cancer Incidence by Age. UK, 2004 Cancer Research UK (http://info.cancerresearchuk.org/cancerstats/types/ prostateincidence/?a=5441) (accessed: 07.01.2008)
9. Cybulski C, Gorski B, Huzarski T, Masojc B, Mierzejewski M (2004) CHEK2 is a multi-organ cancer susceptibility gene. Am J Hum Genet 75: 1131-1135
10. Dong X, Wang L, Taniguchi K, Wang X, Cunningham J (2003) Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet 72: 270-280
11. Dupont W, Plummer W (1990) Power and sample size calculations: a review and computer programme. Control Clin Trials 11: 116-128
12. Edwards S, Kote-Jarai Z, Meitz J (2003) Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 72: 1-12
13. Gronberg H (2003) Prostate cancer epidemiology. The Lancet 361: 859-864
14. Hart D, Hillier MC (1996) Doses to Patients from Medical X-ray Examinations in the UK-1995 Review. National Radiological Protection Board: Chilton
15. Hart D, Jones DG, Wall BF (1994) Estimation of Effective Doses in Diagnostic Radiology from Entrance Surface Dose and Dose-Area-Product Measurements. NRPB-R262. National Radiological Protection Board: Chilton
16. Hart D, Wall BF (2002) Radiation exposure of the UK Population from Medical and Dental X-ray Examinations. National Radiological Protection Board: Chilton
17. Howe O, O'Malley K, Lavin M, Gardner R, Seymour C, Lyng F, Mulvin D, Quinlan D, Mothersill C (2005) Cell death mechanisms associated with G2 radiosensitivity in patients with prostate cancer and benign prostatic hyperplasia. Radiat Res 164: 627-634
18. HPS (2004) Radiation risk in perspective: position statement of the Health Physics Society. Health Physics Society. Volume: Position statement PS010-1 (August 2004), pp 1-3; http://www.hps.org/documents/ risk_ps010-1.pdf, accessed 07 January 2008
19. ICRP (2007) ICRP publication 103: recommendations of the ICRP. In Valentin, J (ed). Annals of the ICRP. International Commission on Radiological Protection, Vol. 37, Issues 2-4, April-June 2007. Elsevier, pp 137-246
20. Meittinen OS (1974) Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 99: 325-332
21. Preston DL, Mattsson A, Holmberg E, Shore R, Hlidreth NG, Boice JD (2002) Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 158: 220-235
22. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K (2003a) Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality:1950-1997. Radiat Res 160: 381-407
23. Ruiz-Cruces R, Ruiz F (2000) Patient dose from barium procedures. Br J Radiol 73: 752-761
24. Selley S, Donovan J, Faulkner A, Coast J, Gillatt D (1997) Diagnosis, management and screening of early localised prostate cancer. Health Technol Assess 1: 1-96
25. Walley T, Mantgani A (1997) The UK General Practice Research Database. Lancet 350: 1097-1099